Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Muzahir H. Tayebjee, Sunil Nadar, Andrew D. Blann, D. Gareth Beevers, Robert J. MacFadyen, Gregory Y H Lip
Fingerprint
Dive into the research topics of 'Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)'. Together they form a unique fingerprint.